NanoSphere Health Sciences Inc. (NSHS.CN)
CAD 0.09
(70.0%)
CAD 0.09
(70.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -53.69 Thousand | -67.66 Thousand | -64.68 Thousand | -47.25 Thousand | -1.07 Million | -3.23 Million |
| Net Income | -228.12 Thousand | -281.75 Thousand | -356.27 Thousand | -591.22 Thousand | -3.46 Million | -4.51 Million |
| Depreciation & Amortization | - | - | - | 13.76 Thousand | 134.24 Thousand | 44.77 Thousand |
| Deferred income taxes | - | - | - | 3723.00 | 1.25 Million | - |
| Stock-based compensation | 2988.00 | 9875.00 | 23.3 Thousand | 88.66 Thousand | 320.46 Thousand | 355.89 Thousand |
| Change in working capital | 198.89 Thousand | 160.65 Thousand | 328.19 Thousand | 437.96 Thousand | 661.94 Thousand | 315.51 Thousand |
| Other non-cash items | 175.06 | 43.56 Thousand | -59.9 Thousand | -153.00 | 13.75 Thousand | 559.65 Thousand |
| Investing Cash Flow | - | - | - | - | -382.37 Thousand | -1.5 Million |
| Investments in PPE | - | - | - | - | -52.99 Thousand | -302.16 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -329.38 Thousand | -1.2 Million |
| Financing Cash Flow | - | - | 182.42 Thousand | 34.26 Thousand | 1.27 Million | 1.29 Million |
| Debt repayment | - | - | - | -29.8 Thousand | -85.96 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 190.57 Thousand | - | 1.4 Million | 1.01 Million |
| Other Financing Activities | - | - | -8144.00 | 64.07 Thousand | -40.65 Thousand | 282.86 Thousand |
| Accounts receivables | -3.62 | -3.28 | 1.03 | 44.70 | -21.57 | -13.85 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 202.5 Thousand | 160.65 Thousand | 328.19 Thousand | 437.91 Thousand | 661.96 Thousand | -41.62 |
| Cash at beginning of period | 55.01 Thousand | 130.75 Thousand | 12.94 Thousand | 33.45 Thousand | 211.62 Thousand | 3.7 Million |
| Cash at end of period | 9316.00 | 55.01 Thousand | 130.75 Thousand | 12.94 Thousand | 33.45 Thousand | 211.62 Thousand |
| Capital Expenditure | - | - | - | - | -52.99 Thousand | -302.16 Thousand |
| Effect of forex changes on cash | 8004.00 | -8086.00 | 63.00 | -7520.00 | 5102.00 | -41.05 Thousand |
| Net cash flow / Change in cash | -45.69 Thousand | -75.74 Thousand | 117.8 Thousand | -20.5 Thousand | -178.17 Thousand | -3.49 Million |
| Free Cash Flow | -53.69 Thousand | -67.66 Thousand | -64.68 Thousand | -47.25 Thousand | -1.13 Million | -3.54 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -61.05 Thousand | -41.29 Thousand | -54.94 Thousand | -228.12 Thousand | -41.47 Thousand | -78.15 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | -3.00 | 2988.00 | 247.00 | 1384.00 |
| Change in working capital | 66.45 Thousand | 19.43 Thousand | 71.94 Thousand | 198.89 Thousand | 9984.00 | 85.64 Thousand |
| Other non-cash items | 49.42 Thousand | 50.41 Thousand | 46.08 Thousand | 175.06 | 4456.00 | -4656.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 29.87 Thousand | -1140.00 | -1004.00 | -3.62 | -0.51 | -1.55 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 36.57 Thousand | - | - | - | 9984.51 | 85.64 Thousand |
| Cash at beginning of period | 8126.00 | 9316.00 | 11.36 Thousand | 55.01 Thousand | 26.19 Thousand | 33.59 Thousand |
| Cash at end of period | 22.68 Thousand | 8126.00 | 9316.00 | 9316.00 | 11.36 Thousand | 26.19 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -3693.00 | -9174.00 | 7811.00 | 8004.00 | 11.96 Thousand | -11.63 Thousand |
| Net cash flow / Change in cash | 14.55 Thousand | -1190.00 | -2053.00 | -45.69 Thousand | -14.82 Thousand | -7405.00 |
| Free Cash Flow | 18.25 Thousand | 7984.00 | -9864.00 | -53.69 Thousand | -26.78 Thousand | 4225.00 |
ERMA
300748
2764
ADV
TIGER
CHMBBRW